{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Pyroxamide",
  "nciThesaurus": {
    "casRegistry": "382180-17-8",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A synthetic derivative of hydroxamic acid with antineoplastic properties, Pyroxamide inhibits histone deacetylases involved in transcription; induces hyperacetylation of core histones, modulating chromatin structure and affecting transcription of some genes that inhibit tumor growth; and induces growth arrest and apoptosis. Pyroxamide is used in clinical studies for cancer chemotherapy.",
    "fdaUniiCode": "12N86DSS23",
    "identifier": "C2801",
    "preferredName": "Pyroxamide",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C1946"
    ],
    "synonyms": [
      "PYROXAMIDE",
      "Pyroxamide",
      "Suberoyl-3-aminopyridineamide Hydroxamic Acid",
      "pyroxamide"
    ]
  }
}